Isolated micronodular adrenocortical disease

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

5 events
Jan 2026A Phase I Trial of Subcutaneous QLS7305 in Healthy Adults

Qilu Pharmaceutical Co., Ltd. — PHASE1

TrialNOT YET RECRUITING
Aug 2025A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020

Luye Pharma Group Ltd. — PHASE1

TrialRECRUITING
Jul 2025A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Hoffmann-La Roche — PHASE1

TrialRECRUITING
Jun 2025Phase I Study of XTL6001 Injection in Healthy and Obese Subjects

Shanghai Xitaili Biomedicine Technology co., Ltd. — PHASE1

TrialRECRUITING
May 2024MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP

Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Isolated micronodular adrenocortical disease.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Isolated micronodular adrenocortical disease.
Search all trials →
Search clinical trials for Isolated micronodular adrenocortical disease

Recent News & Research

No recent news articles indexed yet for Isolated micronodular adrenocortical disease.
Search PubMed for Isolated micronodular adrenocortical disease

Browse all Isolated micronodular adrenocortical disease news →

Specialist Network

Top 1 by expertise

View all Isolated micronodular adrenocortical disease specialists →

Quick Actions